3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
Related Content
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports of ...
May 22, 2017
May 10, 2017 — Abbott announced CE Mark of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, developed to ...
May 10, 2017
Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses the ...
March 30, 2017
March 30, 2017 — New late-breaking featured clinical research presented today adds strong clinical support for Abbott's ...
March 30, 2017
Feature | Stents Bioresorbable| Dave Fornell
March 21, 2017 — In the late-breaking ABSORB III Trial two year results presented at the American College of Cardiology ...
March 21, 2017
February 2, 2017 — Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR) ...
February 02, 2017
Minneapolis Heart Institute Continues Early Feasibility Trial With Tendyne Device for Smaller Hearts
January 16, 2017 – In 2015, researchers and physicians at the Minneapolis Heart Institute Foundation (MHIF) were the ...
January 16, 2017
The biggest news from the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting this past fall was the results of ...
January 12, 2017
January 9, 2017 — The U.S. Food and Drug Administration (FDA) issued a safety communication today concerning patient ...
January 09, 2017
January 5, 2017 — Abbott announced it completed the acquisition of St. Jude Medical Inc. The transaction provides Abbott ...
January 05, 2017